Ameritas Advisory Services’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Ameritas Advisory Services's XPH Position: Q3 2026 in Review

Ameritas Advisory Services reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 1.3% in Q3 2026, selling an estimated $4.56K and leaving 4,873 shares worth $317K. The position accounts for 0.01% of the portfolio, ranked #928.

Ameritas Advisory Services first reported a position in XPH in Q4 2021 and has held it in 16 quarters since. The position peaked at $661K in Q1 2022. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

• Ameritas Advisory Services held 4,873 shares of State Street SPDR S&P Pharmaceuticals ETF worth $317K as of Q3 2026.
• Ameritas Advisory Services sold 66 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2026, an estimated $4.56K.
• State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Ameritas Advisory Services's portfolio in Q3 2026, its #928 holding.
• Ameritas Advisory Services first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2021 and has held it in 16 quarters since.
• Ameritas Advisory Services's State Street SPDR S&P Pharmaceuticals ETF position peaked at $661K in Q1 2022.
• 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Ameritas Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.